The Protein Kinase C Inhibitor Enzastaurin Exhibits Antitumor Activity against Uveal Melanoma

GNAQ mutations at codon 209 have been recently identified in approximately 50% of uveal melanomas (UM) and are reported to be oncogenic through activating the MAPK/Erk1/2 pathway. Protein kinase C (PKC) is a component of signaling from GNAQ to Erk1/2. Inhibition of PKC might regulate GNAQ mutation-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xinqi, Zhu, Meijun, Fletcher, Jonathan A., Giobbie-Hurder, Anita, Hodi, F. Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257235/
https://www.ncbi.nlm.nih.gov/pubmed/22253748
http://dx.doi.org/10.1371/journal.pone.0029622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257235/
https://www.ncbi.nlm.nih.gov/pubmed/22253748
http://dx.doi.org/10.1371/journal.pone.0029622

Ejemplares similares